0001179110-20-001044.txt : 20200204 0001179110-20-001044.hdr.sgml : 20200204 20200204175814 ACCESSION NUMBER: 0001179110-20-001044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200131 FILED AS OF DATE: 20200204 DATE AS OF CHANGE: 20200204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwartz Carl I. CENTRAL INDEX KEY: 0001573354 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36790 FILM NUMBER: 20575266 MAIL ADDRESS: STREET 1: 20155 N.E. 38TH COURT, UNIT 3104 CITY: AVENTURA STATE: FL ZIP: 33180 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Predictive Oncology Inc. CENTRAL INDEX KEY: 0001446159 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 331007393 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2915 COMMERS DRIVE, STREET 2: SUITE 900 CITY: EAGAN STATE: MN ZIP: 55121 BUSINESS PHONE: 651-389-4800 MAIL ADDRESS: STREET 1: 2915 COMMERS DRIVE, STREET 2: SUITE 900 CITY: EAGAN STATE: MN ZIP: 55121 FORMER COMPANY: FORMER CONFORMED NAME: Precision Therapeutics Inc. DATE OF NAME CHANGE: 20180314 FORMER COMPANY: FORMER CONFORMED NAME: Precision Therapeutic Inc. DATE OF NAME CHANGE: 20180208 FORMER COMPANY: FORMER CONFORMED NAME: Skyline Medical Inc. DATE OF NAME CHANGE: 20130807 4 1 edgar.xml FORM 4 - X0306 4 2020-01-31 0 0001446159 Predictive Oncology Inc. POAI 0001573354 Schwartz Carl I. 3750 LAS VEGAS BLVD. SOUTH APT. 4303 LAS VEGAS NV 89158 1 1 0 0 Chief Executive Officer Common Stock 2020-01-31 4 J 0 50000 A 74430 D Third Amended and Restated Common Stock Purchase Warrant 2020-01-31 4 J 0 119442 D 2024-02-06 Common Stock 119442 0 D Pursuant to an Exchange Agreement, between the Issuer and the Reporting Person, Dr. Schwartz delivered certain Notes and a Warrant to the Company to be cancelled and in exchange received: (a) a new promissory note issued by the Company with amended terms, and (b) a fee of $130,000, payable in the form of 50,000 shares of the Company's common stock, based on a closing bid price of $2.60 on January 30, 2020. Share ownership totals have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on October 29, 2019. The Warrant covered 119,442 shares at exercise prices ranging from $7.04 to $11.88 per share. Currently exercisable. /s/ Carl I. Schwartz, DDS 2020-02-04